
|
Report Date : |
15.11.2006 |
|
Name : |
MONSANTO
INDIA LIMITED |
|
|
|
|
Formerly Known As : |
MONSANTO
CHEMICALS OF INDIA LIMITED |
|
|
|
|
Registered Office : |
Ahura
Centre, 5th Floor, 96, Mahakali Caves Road, Andheri (East), Mumbai
– 400 093, India |
|
|
|
|
Country : |
India
|
|
|
|
|
Financials (as on) : |
31.03.2006 |
|
|
|
|
Date of Incorporation : |
08.12.1949 |
|
|
|
|
Com. Reg. No.: |
11-7912 |
|
|
|
|
CIN No.: [Company Identification No.] |
L74999MH1949PLC007912 |
|
|
|
|
TAN No.: [Tax Deduction & Collection Account No.] |
MUMM19093E |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACM2875L |
|
|
|
|
Legal Form : |
A Public Limited Liability
Company. The shares of the company
are listed on the Stock Exchanges. The
company is a subsidiary of Monsanto Company (now known as Pharmacia Corporation),
USA. |
|
|
|
|
Line of Business : |
Manufacturing
and Marketing of agricultural and industrial chemicals |
|
MIRA’s Rating : |
Aa |
RATING
|
STATUS |
PROPOSED CREDIT LINE |
|
|
71-85 |
Aa |
Possesses adequate
working capital. No caution needed for credit transaction. It has above
average (strong) capability for payment of interest and principal sums |
Large |
|
Maximum Credit Limit : |
USD 13000000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a subsidiary of
Monsanto Company (now known as Pharmacia Corporation) of USA. Available
information indicates high financial responsibility of the company. Financial
position is good. Payments are correct and as per commitments. The company can be
considered normal for business dealings at usual trade terms and conditions. |
|
Registered Office : |
Ahura
Centre, 5th Floor, 96, Mahakali Caves Road, Andheri (East), Mumbai
– 400 093, India |
|
Tel. No.: |
91-22-28246450
/26902100/67029851 |
|
Fax No.: |
91-22-26902111 /26902121/67023361/28244707 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Factories : |
1, 4 & 5, Madhuban
Industrial Estate, Madhuban Dam Road, Rakholi, Silvassa – 396 240, Union
Territory of Dadra & Nagar Haveli, India Moka Road, Srivara Village,
Bellary – 583 103, Karnataka, India Bapirajagudem Village,
Pedavegi Mandal, Vijaya Rai Post, West Godavari Dist. – 534 475, Andhra
Pradesh, India |
|
Name : |
Ms.
Nicole M. Ringenberg |
|
Designation : |
Chairperson |
|
|
|
|
Name : |
Mr. Felipe Osorio |
|
Designation : |
Managing Director |
|
|
|
|
Name : |
Mr. R.C. Khanna |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr. H.C. Asher |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr. William Mailman |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr. Mark J. Deadwyler |
|
Designation : |
Director |
|
|
|
|
Name : |
Mr.
Pradeep Poddar |
|
Designation : |
Director
|
|
|
|
|
OTHER PERSONNEL |
|
|
|
|
|
Name : |
Mr.
Ajai Jain |
|
Designation : |
Company Secretary & Counsel (Legal &
Taxation) |
|
Name of Shareholders |
No. of Shares |
Percentage (%) |
|
Promoters |
6227022 |
72.15 |
|
Mutual Funds |
408560 |
4.74 |
|
Nationalised Banks |
600 |
0.01 |
|
Bodies Corporate |
149207 |
1.73 |
|
Public |
1578506 |
18.29 |
|
NRI/FIIs |
232762 |
2.69 |
|
Others |
34517 |
0.39 |
|
TOTAL |
8631174 |
100.000 |
|
Line of Business : |
Manufacturing
and Marketing of agricultural and industrial chemicals |
The company’s production
status for the year 31.03.2005 was as under:
|
Class of Goods |
Unit |
Installed Capacity |
Actual Production |
|
Formulation |
KL p.a. |
39000 |
7627 |
|
Seeds |
MT p.a. |
30000 |
28788 |
|
No. of Employees : |
400 |
|
|
|
|
Bankers : |
v
Citibank N.A. v
Canara Bank |
|
|
|
|
Facilities : |
-- |
|
|
|
|
Banking Relations : |
Good |
|
|
|
|
Auditors : |
Deloitte Haskins &
Sells Chartered Accountants |
|
Address : |
Mumbai |
|
|
|
|
Associates/Subsidiaries
: |
Maharashtra Hybrid Seeds
Company Limited SUBSIDIARIES v
P. T. Branita Sandhini v
Monsanto Philippines
Inc. v
Monsanto Seeds
(Thailand) Limited v
Monsanto Australia
Limited v
Parry Monsanto Seeds
Limited v
Monsanto Singapore
Pte. Ltd. v
Monsanto (Bangladesh)
Limited v
Monsanto (Malaysia)
Sdn. Bhd. v
Monsanto Holdings
Private Limited |
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10,000,000 |
Equity
Shares |
Rs. 10/- each |
Rs. 100.000 millions |
Issued & Subscribed
Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
8,631,574 |
Equity Shares |
Rs. 10/- each |
Rs. 86.316 millions |
Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
8,631,174 |
Equity Shares |
Rs. 10/- each |
Rs. 86.312 millions |
FINANCIAL
DATA
[all figures are in Rupees Millions]
|
SOURCES OF FUNDS |
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
86.312 |
86.312 |
86.312 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
3183.916 |
3735.657 |
3193.416 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
NETWORTH
|
3270.228 |
3821.969 |
3279.728 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
0.000 |
20.000 |
20.000 |
|
TOTAL
BORROWING
|
0.000 |
20.000 |
20.000 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
7.282 |
6.743 |
|
|
|
|
|
|
|
TOTAL
|
3270.228 |
3849.251 |
3306.471 |
|
|
|
|
|
|
|
APPLICATION OF FUNDS
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block]
|
673.171 |
645.114 |
587.504 |
|
Capital work-in-progress
|
81.194 |
0.000 |
46.174 |
|
|
|
|
|
|
|
INVESTMENT
|
501.665 |
2016.483 |
0.002 |
|
DEFERREX TAX ASSETS
|
14.742 |
0.000 |
0.000 |
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES
|
|
|
|
|
|
|
Inventories
|
1028.590
|
855.997 |
984.515 |
|
|
Sundry Debtors
|
303.818
|
338.090 |
646.790 |
|
|
Cash & Bank Balances
|
146.989
|
778.265 |
1693.187 |
|
|
Other Current Assets
|
9.578
|
6.247 |
12.981 |
|
|
Loans & Advances
|
1463.300
|
492.904 |
43.396 |
Total Current Assets
|
2952.275
|
2471.503 |
3380.869 |
|
Less : CURRENT LIABILITIES & PROVISIONS
|
|
|
|
|
|
|
Current Liabilities & Provisions
|
952.819
|
1283.849 |
1095.078 |
Total Current Liabilities
|
952.819
|
1283.849 |
1095.078 |
|
Net Current
Assets
|
1999.456
|
1187.654 |
2672.791 |
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES
|
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
TOTAL
|
3270.228 |
3849.251 |
3306.471 |
|
|
PARTICULARS |
31.03.2006 |
31.03.2005 |
31.03.2004 |
Sales Turnover [including other income]
|
3461.973 |
3909.975 |
3432.446 |
|
|
|
|
|
Profit/(Loss) Before Tax
|
757.617 |
893.513 |
833.306 |
Provision for Taxation
|
29.756 |
125.738 |
140.296 |
Profit/(Loss) After Tax
|
727.680 |
767.775 |
693.010 |
|
|
|
|
|
Export Value
|
355.861 |
357.578 |
429.305 |
|
|
|
|
|
Import Value
|
747.214 |
710.511 |
640.786 |
|
|
|
|
|
Total Expenditure
|
2704.356 |
3016.462 |
2599.140 |
|
PARTICULARS |
|
30.06.2006 (1st Quarter) |
30.09.2006 (2nd Quarter) |
|
Sales
Turnover |
|
1598.800 |
665.000 |
|
Other
Income |
|
41.600 |
36.800 |
|
Total
Income |
|
1640.400 |
701.800 |
|
Total
Expenditure |
|
1072.400 |
609.400 |
|
Operating
Profit |
|
568.000 |
92.400 |
|
Interest |
|
0.700 |
0.700 |
|
Gross
Profit |
|
567.300 |
91.700 |
|
Depreciation |
|
19.900 |
19.600 |
|
Tax |
|
28.600 |
20.800 |
|
Reported
PAT |
|
521.500 |
58.100 |
200606
Quarter 1 - Status of Investor Complaints for the quarter ended 30.06.2006
Complaints Pending at the beginning of the quarter Nil Complaints Received
during the quarter 18 Complaints disposed off during the quarter 18 Complaints
unresolved at the end of the quarter Nil 1. The Company's performance is
affected having regard to the mix of products sold in respective quarters. 2.
The Company has one primary business segment namely 'Agriculture Inputs'. 3.
The Statutory Auditors have carried out a limited review of the results for the
quarter ended 30.06.2006. 4. Previous period's / Year's figures have been
re-grouped wherever necessary to correspond with the current period's figures.
5. The results have been taken on record by the Board of Directors at its
meeting held on 27.07.2006
200609
Quarter 2 - : 1. The Company's
performance is affected having regard to the mix of products sold in respective
quarters. 2. The Company has one primary business segment namely Agriculture
Inputs. 3. Information on investor complaints for the quarter (Nos.) Opening
Balance - 0, New - 8, Disposals - 8 and Closing Balance - 0. 4. The financial
results for the quarter ended 30.09.2006 have been reviewed by the Audit
Committee and by the Board of Directors at their meeting held on 26.10.2006 and
the Statutory Auditors have carried out a limited review of the financial
results. 5. Previous period's/Year's figures have been re-grouped wherever
necessary to correspond with the current period's/year's figures. 6. In terms
of the resolution passed by the shareholders of the Company through Postal
Ballot on 06.10. 2006, the Company has sold its herbicide business under the
trade mark Leader Business (Sulfosulfuron 75% WG) on 09.10.2006 at a
consideration of Rs.301.365 Millions and the effect of this transaction will be
reflected in the financial results of the next quarter. 7. The Directors have
declared an interim dividend of Rs.10/- per share at their meeting held on
26.10.2006 . The record Date for the payment of this interim dividend will be
21.11.2006 .
|
PARTICULARS |
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
Debt Equity Ratio |
0.00 |
0.01 |
0.01 |
|
Long Term Debt Equity Ratio |
0.00 |
0.01 |
0.01 |
|
Current Ratio |
2.41 |
2.58 |
3.48 |
|
TURNOVER RATIOS |
|
|
|
|
Fixed Assets |
3.62 |
4.53 |
4.10 |
|
Inventory |
3.73 |
4.32 |
3.69 |
|
Debtors |
11.02 |
8.07 |
5.48 |
|
Interest Cover Ratio |
47.16 |
46.35 |
64.11 |
|
Operating Profit Margin (%) |
24.22 |
24.96 |
26.69 |
|
Profit Before Interest and
Tax Margin (%) |
21.99 |
22.96 |
24.27 |
|
Cash Profit Margin (%) |
22.91 |
21.31 |
22.29 |
|
Adjusted Net Profit Margin
(%) |
20.69 |
19.31 |
19.87 |
|
Return on Capital Employed
(%) |
21.75 |
25.57 |
27.74 |
|
Return on Net Worth (%) |
20.52 |
21.62 |
22.87 |
STOCK PRICES
|
Face
Value |
Rs. 10.00 |
|
High |
Rs.
1560.00/- |
|
Low |
Rs.
1551.00/- |
HISTORY:
Subject
was incorporated on 8th December 1949 at Mumbai in Maharashtra
having Company Registration Number 7912.
Monsanto India Ltd ( MIL)[formerly known as Monsanto
Chemicals of India], a subsidiary of Monsanto Company, USA is a leading
manufacturer of Agro Chemicals and Hybrid Seeds.
MIL which commenced business in 1949 has lauched first rice herbicide i.e
Machete in 1975. Lasso, Roundup and Leader are MIL's leading brands in Weed
control segment. The company also markets Avadex, a herbicide used on wheat
crops. MIL offered shares to Indian Public in 1989 to reduce foreign equity
holding and to diversify operations.
Monsanto's products are marketed all over the country through an
effective distributor network. It has acquired valuable experience and
expertise in marketing and selling its products in India.
The parent company has integreated its agriculture business in India with
the company. The integreation has been done through acquisition of the entire
share capital of Monsanto Technologies India, a subsidiary of the parent company.
Monsanto Technologies India (MTIL) is engaged in the research,
production, processing and marketing of Corn and Sunflower hybrid seeds. With
the integration MTIL is now the 100% subsidiary of the company. Monsanto India
as a part of this intergration also acquired the entire agriculutral business
from Monsanto Enterprise and the agricultural business related assets from
Monsanto Holdings.
As a consideration of all the three strategic acquisitions, in April
2000, the company issued 23,13,031 equity shares at price of Rs 1480 per equity
shares. During the year 2000-01, the company installed new capacity of 30000 MT
of seeds.
MIL corn drying facility located at Eluru in Andhra Pradesh is
continuously being expanded to meet the increasing demand.
DIRECTORS:
Dr.S.P.Adarkar, Director of the Company,
expired on 7th March, 2005 after a short illness. Dr. S.P. Adarkar helped
writing the early chapters of Monsanto's business in India with many struggles
and many successes too. He had the distinction of having started Monsanto's
Chemical business in India in 1947 and was instrumental in incorporating the
Company in 1949. The Company's first Agro Chemical plant was set up under his
leadership in Lonavla in 1969. Products like Machete and Roundup were
introduced in India under his leadership and they still remain among the very
successful products of Monsanto. Dr. S. P. Adarkar worked with Monsanto India
as the Managing Director upto 1988 and thereafter, as a Director till his last
breath. The Directors record their sincere appreciation of the valuable
contribution of Dr.S.P.Adarkar during his long association with the
Company.
During the year, Mr. Sekhar Natarajan resigned as the Managing Director of the
Company consequent to his relocation to Monsanto Company, USA. The Board wishes
to record its appreciation of the valuable services provided by Mr. Sekhar
Natarajan, whose stewardship helped achieve new heights in Sales and
profitability during his tenure with the Company. Mr. Felipe Osorio has assumed
charge as the new Managing Director of the Company with effect from 1st March,
2005. Mr. Felipe Osorio has served Monsanto Company in several key business
positions successfully, at different locations in the world for over twelve
years.
During the year, Mr. Allen Smith resigned from the Board in view of his
relocation from Asia Pacific Region. The directors would like to place on
record their sincere gratitude for the guidance and contribution made by Mr.
Allen Smith in the growth of the business in India. Pursuant to the provisions
of Article 111 of the Articles of Association, Ms.Nicole M.Ringenberg was
appointed as Chairperson and Non Executive Director of the Company on 22nd
July, 2004 to fill the casual vacancy caused by the resignation of Mr. Allen
Smith.
Ms. Nicole M.Ringenberg - Business Lead-Asia Pacific, has been associated
with Monsanto Company, USA for the past twenty years in various challenging
Finance roles. Presently, she is responsible for overall strategies and
operations of the Asia Pacific Region.
Mr. R. C. Khanna retires by rotation at the ensuing Annual General
Meeting and being eligible, offers himself for re-appointment.
BUSINESS
Subject
is engaged in manufacturing and marketing of agricultural and industrial
chemicals.
The
company pioneered the chemical weed control concept in India and is a leader in
rice herbicides, marketed under the Machete brand. The company also markets
Avadex, a herbicide used on wheat crops.
During the year under report, the company established a new corn drying facility at Eluru in Andhra Pradesh. This plant was commissioned in February 2002.
Generic names of the
principal products of the company are:
|
Item Code
No. (ITC CODE) |
Products
Description |
|
Pesticides/Herbicides |
380830.09 |
|
Hybrid Seeds |
NA |
It is in trade terms with:
The company’s fixed assets of
important value include freehold land, buildings, leasehold improvements, plant
& machinery, furniture, fixtures and office equipments and vehicles.
PARENT COMPANY
˛
Monsanto Company (now
known as Pharmacia Corporation), USA
DIVIDEND:
The Board of Directors declared an interim Dividend of Rs.120/- which
includes a special dividend of Rs.110/- per Equity Share, at the Board meeting
held on 14.11.2005.
The directors are pleased to now recommend to the shareholders, a final
dividend of Rs.10/- per Equity Share.
OPERATIONS:
The net sales during the year under consideration was Rs.3320.000
Millions, lower by 12.4% compared to the previous year. During the year, the
Company scaled down the distribution activity of the third party products that
lowered net sales by compared to the previous year. The Company's Seeds
business registered a healthy growth, continuing a trend since 2001. Overall
Seed realizations and margins were higher than the previous year primarily on
the back of continuing healthy growth in the Corn business. However,
Agrichemicals business realizations and margins were significantly lower
compared to the previous year owing to intense price and product competition
from increasing number of generic players in the industry. This has adversely
impacted the Profit Before Tax from operations, which at Rs.757.600 Millions,
is lower by 15% year on year basis.
The Company fully recognizes the growing importance of the Seeds business
portfolio and has been making critical capital investments over the past few
years. Continuing the trend, during the year under review, the Company has made
a significant investment in a Corn drying facility in Andhra Pradesh in order
to meet the growing demand for quality seeds both in the domestic as well as
international markets. This project is expected to come on stream during the
first quarter of 2007.
MANAGEMENT
DISCUSSION AND ANALYSIS
Industry Structure & Development:
The issue of agricultural development is globally
important and especially crucial for ever-growing population in a developing
country like India. Agriculture has been the mainstay of Indian civilisation
for over many years. Even today, it is the pivotal of the Indian economy, accounting
for about 30 per cent of the GDP and involving about 68 per cent i.e. over 1000
million populations.
In India, an increasing population with an improved standard of living
and continuously declining arable land continue to increase the pressure on
natural resources.
There is an need for the agriculture sector to grow at 5 per cent per
annum to achieve sustained economic growth of 8-9% in India. In order to
increase agricultural productivity, widespread use of high quality hybrids
seeds and planting material is essential. Seeds are a major input and the
initial lever for bolstering agricultural production. Therefore, the seed
industry is perceived as a cost-effective instrument of positive change in
Indian agriculture.
Seeds form the fundamental and crucial input for sustained growth in farm
production, often stimulating the use of new methods, machinery and yield
enhancing agro-inputs. The role of the seed sector is not only to ensure
adequacy in seed quality but also to ensure varietal diversity. Today, the
Indian seed programme boasts one of the biggest seed markets in the world, with
annual sales at around Rs.42000.000 Millions. Of this, domestic offtake
accounts for Rs.40000.000 Millions and sales in the global market account for
the remaining Rs.2000.000 Millions.
The accelerated growth of the private sector began only after the
introduction of the new seed policy in 1988 which ushered in a liberal business
climate. Currently, there are over 200 private seed companies, together with a
few multinational companies, and these tend to focus on low volume, high value
crops with the principal effort being placed on creating hybrids for oilseeds,
maize, cotton and vegetable crops.
The private sector accounts for 70% of the market in terms of market
turnover whereas the public sector has the greater share in terms of volume
sales.
While timely and appropriate monsoons continue to be the most critical
factor by far in determining the success of an agriculture harvest season,
there are other important controllable factors such as pest attacks on crops,
timely availability of high quality seeds, fertilisers and pesticides,
government policies and environment rules and regulations etc, that contribute
in no mean measure to ensuring a successful farming experience for the Indian
farmer. Critical inputs like high quality seeds, fertilizers and pesticides
play a vital role in sustaining and improving the agriculture production and
yield. Thus far, the Seeds and the Indian Crop Protection industry (that
comprises of several Multinationals & Indian companies) have, through their
continued dedicated research and breeding efforts, been able to provide
solutions and products that have benefited the Indian farmer
substantially.
The Insecticides Act, 1968 and the Seeds Act, 1966 and the rules framed
thereunder regulate the production, distribution and sale of crop protection
products. Each product undergoes several exhaustive studies and tests before
permission is granted for commercialization. The agrochemicals and seeds are
marketed through the network of distributors and retailers, which are spread
across the length and breadth of the Country.
Opportunities & Threats:
India today has a critical mass and level of growth that it could use not
only to cater to the growing domestic requirement but also to make a concerted
effort for global trade under provisions of GATT and WTO. Furthermore, India is
endowed with second largest area of farmland, and the largest area of irrigated
land, in the world and, with its huge germplasm diversity, its seed industry is
well placed to serve both domestic and
Financial
Performance:
The margins in the herbicides business continued to decline for yet
another year, under price pressure from competing generic molecules (specially
in the key wheat segment). However, superior product offerings and better mix
continued to improve the margins in the seeds business. The Company continues
to make appropriate capital investments that support its growing business
needs. During the year, an investment of approximately Rs.480.000 Millions was
approved by the Board to be made in enhancing its seed drying capacity with
improved technology.
The Company's operations continued to generate surplus funds to meet all
its requirements without having to resort to external borrowings. The Company
has also earned tax free income by investing surplus cash in mutual
funds.
Outlook:
Through continuous research efforts at providing newer product offerings,
aggressive sales and marketing strategies, a strong brand and distribution
infrastructure and investment in people development, the Company is hopeful of
maintaining its performance going forward. Efforts at offering better
technologies (that provide better value to the farmer while mitigating external
risks) have been generally well received both by the Government and the farmer.
Continued success in these efforts is critical to maintain these growth
prospects.
A commitment to
agriculture
Monsanto
is an agricultural company. Farmers around the world use their innovative
products to address on-farm challenges and reduce agriculture's overall impact
on their environment.
When
farmers succeed, they succeed. So, they take their cue from their farmer
customers. They use the tools of modern biology to support their commitment to
agriculture and to support the farmers that feed, clothe and fuel their growing
world.
We're constantly looking at ways to maximize the potential of seed for farmers - both its yield potential and the technology used to protect it, so farmers can get more out of each seed. Today, farmers use their innovative seed-based products to help them protect their crops, produce healthier foods and better animal feeds for their world.
Today,
they produce leading seed brands in large-acre crops like corn, cotton, and
oilseeds (soybeans and canola), as well as small-acre crops like vegetables.
They also produce leading in-the-seed trait technologies for farmers that are
aimed at protecting their yield, supporting their on-farm efficiency and
reducing their on-farm costs.
As
a company, they remain committed to broadly licensing their seed and trait
technologies to other companies throughout the world. This approach ensures
that farmers can access their products in the varieties that mean the most to
their farm.
In
addition to their seeds and traits business, they also manufacture the world's
best-selling herbicide, Roundup, and other herbicides - used by farmers,
consumers and lawn-and-garden professionals.
Their
business is structured in two segments: Seeds and Genomics, and Agricultural
Productivity.
Seeds
and Genomics
The seed and Genomics segment consists of the company's global seeds and traits
business, and genetic technology platforms - including biotechnology, breeding
and genomics.
Agricultural Productivity
The Agricultural Productivity segment consists primarily of crop protection
products, residential lawn-and-garden herbicide products, and the company's
animal agricultural businesses.
Growth and Leadership Are Top Priorities For The End
Of The Decade, Monsanto Executives Tell European Investors
LONDON (10.11.2006) – Monsanto (NYSE: MON) has a unique window of
opportunity to build on its industry leading position and capitalize on emerging
growth opportunities between now and the end of the decade, company executives
told investors today.
The
company’s remarks came as part of an investor meeting held in London, which
featured presentations by Hugh Grant, chairman, president and chief executive
officer; Robb Fraley, executive vice president and chief technology officer;
and Terry Crews, executive vice president and chief financial officer.
At
the event, Monsanto’s management team outlined key factors expected to drive
the company’s growth through 2010 and confirmed its earnings per share (EPS)
and free cash flow guidance for fiscal-year 2007.
“The
leadership they enjoy today is not accidental,” said Grant. “It
represents their strategic decision to orient their business around their seeds
and traits platform, and then passionately execute against that strategy
literally farm-by-farm and field-by-field.
“While
their early investment gave us a head start, it is their performance – backed
by the industry’s leading R&D pipeline, and coupled with their principles
of relentless innovation, commercial execution and delivery against their
commitments – that will help us build on their leadership in the years ahead,”
said Grant.
Growth Contributors Expected To Expand Window of
Leadership, Deliver Greater Profitability
Monsanto’s
management team has identified six elements which will contribute to the growth
of the company’s seeds and traits business between now and 2010. These include:
its U.S. and ex-U.S. corn seeds and traits business; its international traits
business; its cotton business; its Seminis fruit and vegetable seed business;
and its R&D pipeline.
By
executing its strategy against these six contributors, Monsanto will not only
be able to deliver value to its farmer customers, but expects to grow the
profitability of the business, increasing gross profit as a percent of sales
from 48 percent today, to a target of 51 to 53 percent by the end of the
decade, Grant said.
In outlining the six factors that would drive the company’s gross-profit growth through the end of the decade, Monsanto’s management team highlighted a number of opportunities and new developments, including:
Company
Reiterates Guidance for Fiscal Year 2007
In
the final presentation of the day, Crews reviewed the company’s key financial
projections. He underscored the opportunity created by a company uniquely
positioned for leadership in the seeds-and-traits segment of the agricultural
industry.
Crews
noted that the company continues to expect that its full-year 2007 EPS
guidance, both on a reported and ongoing basis, is expected to be in the range
of $1.50 to $1.57. (For a reconciliation of ongoing EPS, see note 1.)
“At
Monsanto, guidance is a commitment, not an aspiration,” said Crews.
“Their projected 15 to 20 percent growth rate for ongoing EPS in 2007 reflects
their confidence in the substantial organic growth potential of their seeds and
traits, even in a dynamic agricultural market.
“If
they accomplish their objectives over the mid-term, they have a unique window
of opportunity to extend their leadership and reward their shareowners for
their investment in their company.”
Crews
also underscored that the company still expects guidance for free cash flow for
fiscal year 2007 will be in the range of $875 million to $950 million. The
company expects net cash provided by operating activities to be in the range of
$1.3 billion to $1.4 billion, and net cash required by investing activities to
be approximately $500 million for fiscal year 2007. (For a reconciliation of
free cash flow, see note 1.)
2006
European Investor Meeting Background
A live webcast of Monsanto’s European investor briefing will be available through Monsanto’s web site beginning at 3 a.m. Central Standard Time this morning, Friday, 10.11.2006. This webcast is available at:
http://www.monsanto.com/monsanto/layout/investor/financial/presentations.asp.
Following the live broadcast, a replay of the webcast will be available on the
Monsanto web site for two weeks.
Materials
related to this investor briefing, including: the presentation agenda, briefing
slides, transcripts, and speaker bios will also be available through Monsanto’s
web site at: http://www.monsanto.com/monsanto/layout/featured/europe_conference/default.asp.
To
access presentation slides and the simultaneous audio webcast of the
presentation, visitors may need to download Windows Media Player™ prior to
listening to the webcast.
Monsanto
Company a leading global provider of technology-based solutions and
agricultural products that improve farm productivity and food quality.
Cautionary Statements
Regarding Forward-Looking Information:
Certain statements contained in this release are
"forward-looking statements," such as
statements concerning the company's anticipated financial results, current and
future product performance, regulatory approvals, business and financial plans
and other non-historical facts. These statements are based on current
expectations and currently available information. However, since these
statements are based on factors that involve risks and uncertainties, the
company's actual performance and results may differ materially from those
described or implied by such forward-looking statements. Factors that could
cause or contribute to such differences include, among others: continued
competition in seeds, traits and agricultural chemicals; the company's exposure
to various contingencies, including those related to intellectual property
protection, regulatory compliance and the speed with which approvals are
received, and public acceptance of biotechnology products; the success of the
company's research and development activities; the outcomes of major lawsuits,
including proceedings related to Solutia Inc.; developments related to foreign
currencies and economies; successful completion and operation of recent and
proposed acquisitions, including Delta and Pine Land Company; fluctuations in
commodity prices; compliance with regulations affecting their manufacturing;
the accuracy of the company's estimates related to distribution inventory
levels; the company's ability to fund its short-term financing needs and to
obtain payment for the products that it sells; the effect of weather
conditions, natural disasters and accidents on the agriculture business or the
company's facilities; and other risks and factors detailed in the company's
filings with the SEC.
Undue
reliance should not be placed on these forward-looking statements, which are
current only as of the date of this release. The company disclaims any current
intention or obligation to update any forward-looking statements or any of the
factors that may affect actual results.
Notes to editors: DEKALB,
Asgrow and Roundup RReady2Yield are trademarks of Monsanto Company and its
wholly owned subsidiaries.
Monsanto Company
Selected Financial Information
(Dollars in millions)
Unaudited
Ongoing EPS and Free Cash Flow: The presentations of ongoing EPS and free cash flow are not
intended to replace net income (loss), cash flows, financial position or
comprehensive income (loss), and they are not measures of financial performance
as determined in accordance with generally accepted accounting principles
(GAAP) in the United States. The following tables reconcile EBIT, ongoing EPS
and free cash flow to the respective most directly comparable financial measure
calculated in accordance with GAAP.
Reconciliation of EPS to Ongoing EPS: Ongoing EPS is calculated excluding certain
after-tax items which Monsanto does not consider part of ongoing operations.
|
|
Fiscal Year 2007 Target |
Fiscal Year 2006 |
Fiscal Year 2005 |
|
Diluted
Earnings per Share |
$1.50 - $1.57 |
$1.25 |
$0.47 |
|
Tax
Charge on Repatriated Earnings |
-- |
0.04 |
-- |
|
Loss (Income) on
Discontinued Operations |
-- |
0.01 |
(0.02) |
|
Cumulative Effect of
Change in Accounting |
|
0.01 |
|
|
Solutia-Related Charge |
-- |
-- |
0.32 |
|
Tax Benefit on Loss from
European Wheat |
-- |
-- |
(0.19) |
|
Restructuring Charges –
Net |
-- |
-- |
0.01 |
|
Seminis & Stoneville
In-Process R&D |
-- |
-- |
0.45 |
|
Diluted Earnings per
Share from Ongoing |
$1.50 - $1.57 |
$1.31 |
$1.04 |
Reconciliation of Free Cash Flow: Free cash flow represents the total of cash flows from operating
activities and investing activities, as reflected in the Statements of
Consolidated Cash Flows. With respect to the fiscal year 2007 free cash flow
target, Monsanto does not include any estimates or projections of Net Cash
Provided (Required) by Financing Activities because in order to prepare any
such estimate or projection, Monsanto would need to rely on market factors and
conditions that are outside of its control.
|
|
Fiscal
Year 2007 Target |
12
Months Ended |
|
Net Cash Provided by Operating |
$1,375
- $1,450 |
$1,674 |
|
Activities |
|
|
|
Net Cash Required by Investing Activities |
(500) |
(625) |
|
Free Cash Flow |
$875
- $950 |
$1,049 |
|
Net Cash Required by Financing Activities |
NA |
(117) |
|
Cash and Cash
Equivalents |
NA |
3 |
|
Net Increase (Decrease) in Cash and Cash
Equivalents |
NA |
$
935 |
|
Cash and Cash Equivalents at Beginning of Period |
NA |
$
525 |
|
Cash and Cash Equivalents at End of Period |
NA |
$1,460 |
CMT REPORT [Corruption, Money laundering & Terrorism]
The
Public Notice information has been collected from various sources including but
not limited to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION
ON DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.
2] Court
Declaration :
No records exist to suggest that subject is or was the
subject of any formal or informal allegations, prosecutions or other official
proceeding for making any prohibited payments or other improper payments to
government officials for engaging in prohibited transactions or with designated
parties.
3] Asset
Declaration :
No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.
4] Record
on Financial Crime :
Charges or conviction registered
against subject: None
5] Records
on Violation of Anti-Corruption Laws :
Charges or investigation registered
against subject: None
6] Records
on Int’l Anti-Money Laundering Laws/Standards :
Charges or investigation registered
against subject: None
7] Criminal
Records
No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.
8] Affiliation
with Government :
No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.
9] Compensation
Package :
Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.
10] Press Report :
No press reports / filings exists on the subject.
CORPORATE
GOVERNANCE
MIRA
INFORM as part of its Due Diligence do provide comments on Corporate Governance
to identify management and governance. These factors often have been predictive
and in some cases have created vulnerabilities to credit deterioration.
Our
Governance Assessment focuses principally on the interactions between a company’s
management, its Board of Directors, Shareholders and other financial
stakeholders.
CONTRAVENTION
Subject
is not known to have contravened any existing local laws, regulations or
policies that prohibit, restrict or otherwise affect the terms and conditions
that could be included in the agreement with the subject.
FOREIGN
EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US
Dollar |
1 |
Rs. 45.01 |
|
UK
Pound |
1 |
Rs. 84.91 |
|
Euro |
1 |
Rs. 57.48 |
RATING
|
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely
sound financial base with the strongest capability for timely payment of
interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate
working capital. No caution needed for credit transaction. It has above
average (strong) capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial &
operational base are regarded healthy. General unfavourable factors will not
cause fatal effect. Satisfactory capability for payment of interest and
principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is
considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable &
favourable factors carry similar weight in credit consideration. Capability
to overcome financial difficulties seems comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are
apparent. Repayment of interest and principal sums in default or expected to
be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk
exists. Caution needed to be exercised |
Credit not recommended |